Dicerna Pharmaceuticals (NASDAQ:DRNA) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Dicerna Pharmaceuticals their estimated earnings by 52.17%, reporting an EPS of $-0.22 versus an estimate of $-0.46, which surprised analysts.
Revenue was up $14,079,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.94, which was followed by a 6.88% drop in the share price the next day.
Here’s a look at Dicerna Pharmaceuticals’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.41 | -0.37 | -0.03 | -0.20 |
| EPS Actual | -0.53 | -0.39 | -0.49 | -0.29 |
| Revenue Estimate | 91.29M | 46.28M | 67.25M | 51.50M |
| Revenue Actual | 41.34M | 47.60M | 40.96M | 48.88M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
